Intercept Pharm (ICPT) Reports Q4 Loss of $2.02
Tweet
Share
E-mailGet Alerts ICPT Hot Sheet
Join SI Premium – FREE
Intercept Pharm (NASDAQ: ICPT) reported Q4 EPS of ($2.02), versus ($1.32) reported last year.
For earnings history and earnings-related data on Intercept Pharm (ICPT) click here.
For earnings history and earnings-related data on Intercept Pharm (ICPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'
- DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
